ASML Prepares to Reveal Its 2027 EUV Roadmap Amid Both Analyst Optimism and US Scrutiny

ASML faces record EUV order expectations from analysts alongside a US investigation into alleged China export violations, with stock volatility high ahead of earnings.

When ASML reports its second-quarter results on Wednesday, the Dutch lithography giant will find itself caught between two opposing narratives. On one side stands a chorus of Wall Street analysts who have been scrambling to raise price targets, many of them betting on a record wave of extreme ultraviolet (EUV) machine orders. On the other side looms a newly disclosed US investigation into alleged export violations involving China, a market that still accounts for a meaningful slice of revenue.

The stock closed Monday at €1,519.80, a 13% retreat from the 52-week high of €1,748.00 reached on June 30. That leaves the shares up 53.78% for the year, but the recent slide has been sharp enough to push the monthly performance to minus 7.05%. The annualised volatility over the past 30 trading days sits at 64%, and the relative strength index of 47.1 signals neither overbought nor oversold conditions. Investors are pricing in big swings whichever way the earnings go.

A Wave of Target Upgrades That the Stock Hasn't Caught

The divergence between analyst sentiment and price action is striking. Morgan Stanley's Lee Simpson lifted his target on July 8 from €1,660 to €1,830 with an Overweight rating. Deutsche Bank followed with a €1,800 target and a Buy recommendation, but the upgrade landed on a day the stock slid 2.08% to €1,552. Bernstein's David Dai went furthest, raising his target to $2,623 (about €2,400) and citing an "unprecedented AI-driven expansion" in advanced logic and DRAM capacity. His firm now expects 91 EUV system shipments in 2027 and 113 in 2028.

The most dramatic revision came from Susquehanna, which on June 30 raised its target from €1,475 to €2,350 after channel checks suggested ASML's EUV order backlog had stretched beyond a one-year lead time. All these analysts are converging on a single metric: whether ASML can credibly commit to 90 to 100 EUV shipments in 2027. Morgan Stanley has identified that range as the critical threshold that would justify the stock's premium valuation.

The China Cloud

That bullish thesis now has to coexist with fresh political headwinds. Bloomberg reported that US Commerce Secretary Howard Lutnick has directly questioned ASML managers about whether an EUV lithography system may have reached China in violation of international export rules. The specific focus is on transport systems and components that have been restricted under the Wassenaar Arrangement since 2019. ASML has denied the allegations, calling them unfounded and damaging to its reputation.

Adding to the uncertainty, the proposed MATCH Act in the US Congress could expand existing restrictions to cover maintenance and service of older DUV immersion systems in Chinese fabs. That segment generated roughly one-third of ASML's revenue in 2025. The investigation and the legislative risk have kept the stock on the defensive, even as the order pipeline swells.

TSMC Provides a Counterbalance

If there is a bright spot for the EUV monopoly, it is its largest customer. Taiwan Semiconductor Manufacturing Co. reported June revenue of NT$442.68 billion on July 13, a 67.9% jump from a year earlier. For 2026, TSMC plans capital expenditure of $52 billion to $56 billion, with up to 80% allocated to its most advanced nodes. Industry estimates indicate that roughly a quarter of that spending flows into lithography equipment, virtually all of which comes from ASML.

TSMC will report its own second-quarter numbers on July 16, one day after ASML's release. The two earnings calls together will provide the clearest picture yet of whether the AI-driven chip boom is translating into the kind of equipment orders that Bernstein and others are projecting.

What the Market Will Watch on Wednesday

Consensus forecasts peg ASML's quarterly revenue at roughly $10.27 billion and adjusted earnings per share at $7.94. The company itself guided second-quarter net sales in a range of €8.4 billion to €9.0 billion with a gross margin of 51% to 52%. More important than the quarter itself will be management's commentary on three fronts.

First, net EUV orders must confirm the full-year revenue outlook of €36 billion to €40 billion, which was raised from €34 billion to €39 billion in April. Second, investors want updates on the EXE:5200B High-NA systems, which cost between $380 million and $400 million apiece. Progress on customer acceptance of those machines is a leading indicator of ASML's ability to push annual EUV revenue growth to 30% on the way to a €42.7 billion revenue target by 2030. Third, the market expects management to confirm that China's share of the revenue mix will decline to about 20% in 2026, consistent with tightening export controls.

A Buyback Running in the Background

While the political and earnings drama unfolds, ASML continues its share repurchase programme. Daily filings show the company buying roughly 10,000 shares per trading session at a value of about €15.87 million, with weighted average prices ranging from €1,525 to €1,611 recently. The buyback provides a floor of sorts, but it is the EUV shipment number for 2027 — the one figure that every analyst upgrade ultimately hinges on — that will determine whether the stock can reclaim its June high or slip further under the weight of regulatory uncertainty.